Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Drug Candidates
100.0
%
| 92 | 100.0 % | 90 | 100.0 % | -2.10% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Rest of World
87.3
%
| 82 | 89.3 % | 79 | 87.3 % | -4.35% |
United States
12.7
%
| 10 | 10.7 % | 11 | 12.7 % | +16.66% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Howard Robin
CEO | Chief Executive Officer | 71 | 06-12-31 |
Robert Chess
CHM | Chairman | 66 | 91-11-30 |
Sandra Gardiner
DFI | Director of Finance/CFO | 58 | 23-04-16 |
Chief Tech/Sci/R&D Officer | 49 | 15-06-30 | |
Mary Tagliaferri
CTO | Chief Tech/Sci/R&D Officer | 58 | 14-12-31 |
Vivian Wu
IRC | Investor Relations Contact | - | 18-10-31 |
Robert Bacci
HRO | Human Resources Officer | - | 00-12-31 |
Mark Wilson
LAW | General Counsel | 52 | 02-04-30 |
Jennifer Ruddock
PRN | Corporate Officer/Principal | - | 03-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
R. Scott Greer
BRD | Director/Board Member | 65 | 09-12-31 |
Roy A. Whitfield
BRD | Director/Board Member | 70 | 00-07-31 |
Robert Chess
CHM | Chairman | 66 | 91-11-30 |
Howard Robin
CEO | Chief Executive Officer | 71 | 06-12-31 |
Jeff Ajer
BRD | Director/Board Member | 61 | 17-09-20 |
Myriam Curet
BRD | Director/Board Member | 67 | 19-12-15 |
Diana Brainard
BRD | Director/Board Member | 53 | 21-11-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 183,617,817 | 182,108,535 ( 99.18 %) | 0 | 99.18 % |
Company contact information
Nektar Therapeutics
455 Mission Bay Boulevard South
94158, San Francisco
+415 482 5300
http://www.nektar.comGroup companies
Name | Category and Sector |
---|---|
Nektar Therapeutics (India) Pvt Ltd.
Nektar Therapeutics (India) Pvt Ltd. BiotechnologyHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics (India) Pvt Ltd. develops biopharmaceutical products. The private company is based in Hyderabad, India. |
Biotechnology
|
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |